ZBIO Earnings Zenas Biopharma, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–11 of 11
| Q1 2026 | 2026-03-31 | -1.46 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -8.44 | 2026-03-16 | 10-K |
| Q3 2025 | 2025-09-30 | -3.27 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -2.05 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.80 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -11.89 | 2026-03-16 | 10-K |
| Q3 2025 | 2024-09-30 | -28.83 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -42.15 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -17.89 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -24.25 | 2025-03-11 | 10-K |
| Q3 2024 | 2023-09-30 | -8.21 | 2024-11-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.